Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury

作者：Yuan Gao, Zhijun Cao, Xi Yang, Mohamed A. Abdelmegeed, Jinchun Sun, Si Chen, Richard D. Beger, Kelly J. Davis, William F. Salminen, Byoung‐Joon Song, Donna L. Mendrick, Li‐Rong Yu · 发表于：PROTEOMICS - CLINICAL APPLICATIONS · 年份：2016 · DOI：10.1002/prca.201600123 · 被引用次数：45 · 研究领域：Drug-Induced Hepatotoxicity and Protection、Heme Oxygenase-1 and Carbon Monoxide、Inflammatory mediators and NSAID effects

PURPOSE: Overdose of acetaminophen (APAP) is a major cause of acute liver failure. This study was aimed to identify pathways related to hepatotoxicity and potential biomarkers of liver injury. EXPERIMENTAL DESIGN: Rats were treated with low (100 mg/kg) and high (1250 mg/kg) doses of APAP, and liver tissues at 6 and 24 h post-treatment were analyzed using a proteomic approach of 16O/18O labeling and 2D-LC-MS/MS. RESULTS: Molecular pathways evolved progressively from scattered and less significant perturbations to more focused and significant alterations in a dose- and time-dependent manner upon APAP treatment. Imbalanced expression of hemeoxygenase 1 (HMOX1) and biliverdin reductase A (BLVRA) was associated with hepatotoxicity. Protein abundance changes of a total of 31 proteins were uniquely correlated to liver damage, among which a dramatic increase of HMOX1 levels in plasma was observed. Liver injury-associated significant elevation of plasma HMOX1 was further validated in mice treated with APAP. CONCLUSIONS AND CLINICAL RELEVANCE: This study unveiled molecular changes associated with APAP-induced liver toxicity at the pathway levels and identified HMOX1 as a potential plasma biomarker of liver injury.